The role of estrogen, prolactin, pregnancy and androgen (including DHEA) in SLE is reviewed. A comlex interaction of multiple sex hormones is involved in SLE.
Get full access to this article
View all access options for this article.
References
1.
1 Petri MRobinson C . Oral contraceptives and systemic lupus erythematosus.Arthritis Rheum1997; 40: 797 – 803 .
2.
2 Petri MHoward DRepke J . Frequency of lupus flare in pregnancy: the Hopkins Lupus Pregnancy Center experience.Arthritis Rheum1991; 34: 1538 – 1545 .
3.
3 Grimaldi CMCleary JDagtas ASMoussai DDiamond B . Estrogen alters thresholds for B cell apoptosis and activation.J Clin Invest2002; 109: 1625 – 1633 .
4.
4 Bynoe MSGrimaldi CMDiamond B . Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells.Proc Natl Acad Sci USA2000; 97: 2703 – 2708 .
5.
5 Grimaldi CM . Sex and systemic lupus erythematosus: the role of the sex hormones estrogen and prolactin on the regulation of autoreactive B cells.Curr Opin Rheumatol2006; 18: 456 – 461 .
6.
6 Grimaldi CMJeganathan VDiamond B . Hormonal regulation of B cell development: 17 beta-estradiol impairs negative selection of high-affinity DNA-reactive B cells at more than one developmental checkpoint.J Immunol2006; 176: 2703 – 2710 .
7.
7 Peeva EVenkatesh JDiamond B . Tamoxifen blocks estrogen-induced B cell maturation but not survival.J Immunol2005; 175: 1415 – 1423 .
8.
8 Rider VKeltner SAbdou NI . Increased estrogen-dependent expression of calcineurin in female SLE T cells is regulated by multiple mechanisms.J Gend Specif Med2003; 6: 14 – 21 .
9.
9 Rider VJones SREvans MAbdou NI . Molecular mechanisms involved in the estrogen-dependent regulation of calcineurin in systemic lupus erythematosus T cells.Clin Immunol2000; 95: 124 – 134 .
10.
10 Evans MJMacLaughlin SMarvin RDAbdou NI . Estrogen decreases in vitro apoptosis of peripheral blood mononuclear cells from women with normal menstrual cycles and decreases TNF-alpha production in SLE but not in normal cultures.Clin Immunol Immunopathol1997; 82: 258 – 262 .
11.
11 Hughes GCClark EA . Regulation of dendritic cells by female sex steroids: relevance to immunity and autoimmunity.Autoimmunity2007; 40: 470 – 481 .
12.
12 Aronica SMDozier AFanti PNazareth M . Altered bone marrow cell sensitivity in the lupus-prone NZB/W mouse: regulation of CFU-GM colony formation by estrogen, tamoxifen and thrombopoietin.Lupus2000; 9: 271 – 277 .
13.
13 Yurino HIshikawa SSato T . Endocrine disruptors (environmental estrogens) enhance autoantibody production by B1 cells.Toxicol Sci2004; 81: 139 – 147 .
14.
14 Schoenroth LJHart DAPollard KMFritzler MJ . The effect of the phytoestrogen coumestrol on the NZB/W F1 murine model of systemic lupus.J Autoimmun2004; 23: 323 – 332 .
15.
15 Sakabe KYoshida TFuruya HKayama FChan EK . Estrogenic xenobiotics increase expression of SS-A/Ro autoantigens in cultured human epidermal cells.Acta Derm Venereol1998; 78: 420 – 423 .
17 Weidler CHarle PSchedel JSchmidt MScholmerich JStraub RH . Patients with rheumatoid arthritis and systemic lupus erythematosus have increased renal excretion of mitogenic estrogens in relation to endogenous antiestrogens.J Rheumatol2004; 31: 489 – 494 .
18.
18 McAlindon TEGulin JChen TKlug TLahita RNuite M . Indole-3-carbinol in women with SLE: effect on estrogen metabolism and disease activity.Lupus2001; 10: 779 – 783 .
19.
19 Roubinian JTalal NSiiteri PKSadakian JA . Sex hormone modulation of autoimmunity in NZB/NZW mice.Arthritis Rheum1979; 22: 1162 – 1169 .
20.
20 Steinberg ADMelez KARaveche ES . Approach to the study of the role of sex hormones in autoimmunity.Arthritis Rheum1979; 22: 1170 – 1176 .
21.
21 Verthelyi DAnsar Ahmed S . Characterization of estrogen-induced autoantibodies to cardiolipin in non-autoimmune mice.J Autoimmun1997; 10: 115 – 125 .
22.
22 Sanchez-Guerrero JKarlson EWLiang MHHunter DJSpeizer FEColditz GA . Past use of oral contraceptives and the risk of developing systemic lupus erythematosus.Arthritis Rheum1997; 40: 804 – 808 .
23.
23 Costenbader KHFeskanich DStampfer MJKarlson EW . Reproductive and menopausal factors and risk of systemic lupus erythematosus in women.Arthritis Rheum2007; 56: 1251 – 1262 .
24.
24 Cooper GSDooley MATreadwell ELSt Clair EWGilkeson GS . Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study.Arthritis Rheum2002; 46: 1830 – 1839 .
25.
25 Jungers PDougados MPelissier C . Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus.Arthritis Rheum1982; 25: 618 – 623 .
26.
26 Julkunen HA . Oral contraceptives in systemic lupus erythematosus: side-effects and influence on the activity of SLE.Scand J Rheumatol1991; 20: 427 – 433 .
27.
27 Buyon JPKalunian KCSkovron ML . Can women with systemic lupus erythematosus safely use exogenous estrogens?J Clin Rheumatol1995; 1: 205 – 212 .
28.
28 Petri MKim MYKalunian KC . Combined oral contraceptives in women with systemic lupus erythematosus.N Engl J Med2005; 353: 2550 – 2558 .
29.
29 Sanchez-Guerrero JUribe AGJimenez-Santana L . A trial of contraceptive methods in women with systemic lupus erythematosus.N Engl J Med2005; 353: 2539 – 2549 .
30.
30 Baillargeon JPMcClish DKEssah PANestler JE . Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis.J Clin Endocrinol Metab2005; 90: 3863 – 3870 .
31.
31 Buyon JPetri MAKim MY . The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial.Ann Intern Med2005; 142: 953 – 962 .
32.
32 Peeva EZouali M . Spotlight on the role of hormonal factors in the emergence of autoreactive B-lymphocytes.Immunol Lett2005; 101: 123 – 143 .
33.
33 Peeva EGrimaldi CSpatz LDiamond B . Bromocriptine restores tolerance in estrogen-treated mice.J Clin Invest2000; 106: 1373 – 1379 .
34.
34 Elbourne KBKeisler DMcMurray RW . Differential effects of estrogen and prolactin on autoimmune disease in the NZB/NZW F1 mouse model of systemic lupus erythematosus.Lupus1998; 7: 420 – 427 .
35.
35 Walker SE . Prolactin: an immune-stimulating peptide that regulates other immune-modulating hormones.Lupus1993; 2: 67 – 69 .
36.
36 Walker SE . Modulation of hormones in the treatment of lupus.Am J Manag Care2001; 7 (16 Suppl): S486 – S489 .
37.
37 Clowse MEMagder LSWitter FPetri M . The impact of increased lupus activity on obstetric outcomes.Arthritis Rheum2005; 52: 514 – 521 .
38.
38 Lockshin MD . Pregnancy does not cause systemic lupus erythematosus to worsen.Arthritis Rheum1989; 32: 665 – 670 .
39.
39 Meehan RTDorsey JK . Pregnancy among patients with systemic lupus erythematosus receiving immunosuppressive therapy.J Rheumatol1987; 14: 252 – 258 .
40.
40 Doria ACutolo MGhirardello A . Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus.Arthritis Rheum2002; 47: 202 – 209 .
41.
41 Van Griensven MBergijk ECBaelde JJDe Heer EBruijn JA . Differential effects of sex hormones on autoantibody production and proteinuria in chronic graft-versus-host disease-induced experimental lupus nephritis.Clin Exp Immunol1997; 107: 254 – 260 .
42.
42 Vennemann FTholen S . Sex hormones in lupus erythematosus.Z Hautkr1986; 61: 791 – 799 .
43.
43 Dougados MNahoul KBenhamou LJungers PLaplane DAmor B . Study of plasma androgens in women with autoimmune diseases.Rev Rhum Mal Osteoartic1984; 51: 145 – 149 .
44.
44 Feher KGBencze GUjfalussy JFeher T . Serum steroid hormone levels in systemic lupus erythematosus (SLE).Acta Med Hung1987; 44: 321 – 327 .
45.
45 Jungers PNahoul KPelissier CDougados MTron FBach JF . Low plasma androgens in women with active or quiescent SLE.Arthritis Rheum1982; 25: 454 – 457 .
46.
46 Verthelyi DPetri MYlamus MKlinman DM . Disassociation of sex hormone levels and cytokine production in SLE patients.Lupus2001; 10: 352 – 358 .
47.
47 Hedman MNilsson Ede la Torre B . Low sulpho-conjugated steroid hormone levels in systemic lupus erythematosus (SLE).Clin Exp Rheumatol1989; 7: 583 – 588 .
48.
48 Zietz BReber TOertel MGluck TScholmerich JStraub RH . Altered function of the hypothalamic stress axes in patients with moderately active systemic lupus erythematosus. II. Dissociation between androstenedione, cortisol, or dehydroepiandrosterone and interleukin 6 or tumor necrosis factor.J Rheumatol2000; 27: 911 – 918 .
49.
49 Vogl DFalk WDorner MScholmerich JStraub RH . Serum levels of pregnenolone and 17-hydroxypregnenolone in patients with rheumatoid arthritis and systemic lupus erythematosus: relation to other adrenal hormones.J Rheumatol2003; 30: 269 – 275 .
50.
50 Straub RHZeuner MAntoniou EScholmerich JLang B . Dehydroepiandrosterone sulfate is positively correlated with soluble interleukin 2 receptor and soluble intercellular adhesion molecule in systemic lupus erythematosus.J Rheumatol1996; 23: 856 – 861 .
51.
51 Liu CZhou HQu RLiu Z . Effects of sex hormones on apoptosis in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.Chin Med J (Engl)2001; 114: 291 – 293 .
52.
52 Suzuki NSuzuki TSakane T . Hormones and lupus: defective dehydroepiandrosterone activity induces impaired interleukin-2 activity of T lymphocytes in patients with systemic lupus erythematosus.Ann Med Interne (Paris)1996; 147: 248 – 252 .
53.
53 Lucas JAAhmed SACasey MLMacDonald PC . Prevention of autoantibody formation and prolonged survival in New Zealand black/New Zealand white F1 mice fed dehydroisoandrosterone.J Clin Invest1985; 75: 2091 – 2093 .
54.
54 Matsunaga AMiller BCCottam GL . Dehydroisoandrosterone prevention of autoimmune disease in NZB/W F1 mice: lack of an effect on associated immunological abnormalities.Biochim Biophys Acta1989; 992: 265 – 271 .
55.
55 Yang BCLiu CWChen YCYu CK . Exogenous dehydroepiandrosterone modified the expression of T helper-related cytokines in NZB/NZW F1 mice.Immunol Invest1998; 27: 291 – 302 .
56.
56 Petri MALahita RGVan Vollenhoven RF . Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.Arthritis Rheum2002; 46: 1820 – 1829 .
57.
57 Petri MAMease PJMerrill JT . Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus.Arthritis Rheum2004; 50: 2858 – 2868 .
58.
58 Chang DMChu SJChen HCKuo SYLai JH . Dehydroepiandrosterone suppresses interleukin 10 synthesis in women with systemic lupus erythematosus.Ann Rheum Dis2004; 63: 1623 – 1626 .
59.
59 Hartkamp AGeenen RGodaert GLBijl MBijlsma JWDerksen RH . The effect of dehydroepiandrosterone on lumbar spine bone mineral density in patients with quiescent systemic lupus erythematosus.Arthritis Rheum2004; 50: 3591 – 3595 .
60.
60 Mease PJGinzler EMGluck OS . Effects of prasterone on bone mineral density in women with systemic lupus erythematosus receiving chronic glucocorticoid therapy.J Rheumatol2005; 32: 616 – 621 .
